These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24227477)

  • 21. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST.
    Guagliumi G; Capodanno D; Ikejima H; Bezerra HG; Sirbu V; Musumeci G; Fiocca L; Lortkipanidze N; Vassileva A; Tahara S; Valsecchi O; Costa MA
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):510-8. PubMed ID: 22431208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the stent length on long-term clinical outcomes following newer-generation drug-eluting stent implantation.
    Choi IJ; Koh YS; Lim S; Kim JJ; Chang M; Kang M; Hwang BH; Kim CJ; Kim TH; Seo SM; Shin DI; Park MW; Choi YS; Park HJ; Her SH; Kim DB; Kim PJ; Lee JM; Park CS; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Seung KB
    Am J Cardiol; 2014 Feb; 113(3):457-64. PubMed ID: 24332246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
    Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thin-strut drug-eluting stents are more favorable for severe calcified lesions after rotational atherectomy than thick-strut drug-eluting stents.
    Lee Y; Tanaka A; Mori N; Yoshimura T; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    J Invasive Cardiol; 2014 Feb; 26(2):41-5. PubMed ID: 24486659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients.
    Sanidas EA; Maehara A; Mintz GS; Kubo T; Gupta A; Apfelbaum MA; Hakim D; Moses JW; Mancini DM; Rabbani LE
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):429-35. PubMed ID: 22461357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I; Sanidas E; Hasegawa T; Koo BK; Honda Y; Fitzgerald PJ; Verheye S
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1062-70. PubMed ID: 24478226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation of longitudinal stent deformation in a patient-specific coronary artery.
    Ragkousis GE; Curzen N; Bressloff NW
    Med Eng Phys; 2014 Apr; 36(4):467-76. PubMed ID: 24613503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of intravascular ultrasound in guiding coronary interventions.
    Song HG; Kang SJ; Mintz GS
    Echocardiography; 2018 Apr; 35(4):520-533. PubMed ID: 29679449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal deformation of drug-eluting stents: evaluation by multislice computed tomography.
    Romaguera R; Roura G; Gomez-Lara J; Ferreiro JL; Gracida M; Teruel L; de Albert M; Ariza A; Gomez-Hospital JA; Cequier A
    J Invasive Cardiol; 2014 Apr; 26(4):161-6. PubMed ID: 24717272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Roy P; Steinberg DH; Sushinsky SJ; Okabe T; Pinto Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Weissman NJ; Lindsay J; Waksman R
    Eur Heart J; 2008 Aug; 29(15):1851-7. PubMed ID: 18550555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population.
    Hur SH; Kang SJ; Kim YH; Ahn JM; Park DW; Lee SW; Yun SC; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):407-16. PubMed ID: 21805605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A higher volume of fibrotic tissue on virtual histology prior to coronary stent implantation predisposes to more pronounced neointima proliferation.
    Haine S; Wouters K; Miljoen H; Vandendriessche T; Claeys M; Bosmans J; Vrints C
    Acta Cardiol; 2018 Apr; 73(2):171-178. PubMed ID: 28799447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions.
    Cho S; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Contemp Clin Trials; 2015 Jan; 40():90-4. PubMed ID: 25433202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.